JL15003
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JL15003, covering 2026-04-03 to 2026-04-03. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Study to Evaluate the Safety and Tolerability of JL15003 Injection in Patients With Recurrent Glioblastoma [Phase 1]